20 June 2013
Keywords: genta, begins, trials, novel, oral, taxane, biopharmaceutical
Article | 19 January 2009
Genta, a US biopharmaceutical company focused on delivering innovative products for the treatment of cancer, has initiated a new clinical
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 January 2009
19 June 2013
© 2013 thepharmaletter.com